Top
City scape

Biopharmaceutical Engineering

MEngSc Biopharmaceutical Engineering
Graduate Taught (level 9 nfq, credits 90)
The MEngSc in Biopharmaceutical Engineering programme provides substantial coverage of scientific, technical, management and regulatory issues associated with this industry. The aim of this programme is to offer an internationally recognised high quality flexible curriculum, which follows the latest developments in science and technology. This programme is suitable for Science and Engineering graduates wishing to obtain a qualification which is highly relevant to the biopharmaceutical industry.

Who should apply?
Full Time option suitable for:
Domestic(EEA) applicants: Yes
International (Non EEA) applicants currently residing outside of the EEA Region. Yes

Part Time option suitable for:
Domestic(EEA) applicants: Yes
International (Non EEA) applicants currently residing outside of the EEA Region. No

Programme Outcomes
-Demonstrate an understanding of the scientific principles involved in the development of a biopharmaceutical production process
-Understand the engineering principles underlying the production of biopharmaceuticals
-Demonstrate an integrated knowledge of GMP and the regulatory issues involved in biopharmaceutical production
-Apply their knowledge of biopharmaceutical production processes to design, equip and manage a biopharmaceutical production facility
-Demonstrate the ability to work as part of a design team for the development of a new production facility
-Demonstrate an understanding and appreciation of the challenges involved in the downstream purification of biopharmaceuticals
-Demonstrate an understanding of the fundamentals of process control when applied to growth of mammalian cells in bioreactors
-Demonstrate an appreciation of the concept and practice of independent research in specialised topics in biopharmaceutical engineering

Vision & Values Statement
The MEngSc Biopharmaceutical Engineering programme provides intensive training in the requisite skills for a professional engineer or scientist in the biopharmaceutical or related sector. The programme provides substantial coverage of the scientific, technical, management and regulatory issues associated with this industry. The programme's teaching methods are highly interactive and varied and student learning is assessed using a variety of assessment methodology including exams, assignments, case studies and presentations. Students complete a research project which consolidates their basic knowledge of the course content and provides intensive research experience and training. The course content addresses the principal scientific and engineering challenges involved in the design, operation and management of biopharmaceutical production facilities. It is anticipated that graduates from this programme will play an important role in the development, design and operation of biopharmaceutical processes throughout the industry in the coming years.

Entry requirements

- An honours undergraduate degree (NFQ level 8) with a minimum upper second class honours or international equivalence in a relevant Engineering, Science or Technology programme. However, all applicants will be assessed on a case-by-case basis and relevant or extensive work experience will be taken into account, so that in certain exceptional cases an award at a lower level or a 2.2 classification may be considered.

- Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent.

Duration

1 year full time - T070, 2 years part time - T015.

Number of credits

90

Careers or further progression

Careers & Employability
Your career opportunities upon graduation from this programme are exemplary. Ireland is a world player in pharmaceutical and biopharmaceutical production.

The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately, 120 overseas companies have plants in Ireland, including many of the largest pharmaceutical and biopharmaceutical companies in the world including AbbVie, Amgen, Biomarin, BMS, Genzyme, GSK, Janssen Biologics (Ireland), Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Shire, and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities.

Further enquiries

Contact Name: Katie O'Neill
Contact Number: +353 (0)1 716 1781

Subjects taught

Stage 1 - Core
Animal Cell Culture Technology
CHEN40040

Bioreactor Modelling and Control
CHEN40060

Bioprocessing Laboratory
CHEN40090

Facility Design and Operation
CHEN40110

Biopharmaceutical Industry Regulation and Management
CHEN40120

Bioprocess Scale-up and Technology Transfer
CHEN40130

Biopharmaceutical Engineering Project
CHEN40140

Downstream Processing & Sterile Fill Finish
CHEN40460

Lean Sigma Biopharma Process
CHEN40480

Bioprocess Design
CHEN40530

Bioanalytical Science for Biopharma
CHEN40630

Regulatory Affairs in Science
PHAR40240

Stage 1 - Option
Molecular Genetics and Biotech
BMOL20090

Principles of Biopharmaceutical Engineering
CHEN40020

Comment

Facilities and Resources
This programme is closely linked with the National Institute for Bioprocessing Research and Training (NIBRT), which is a global centre of excellence for training and research in bioprocessing. NIBRT offers a quality training and research experience not previously possible anywhere in the world. At the heart of the NIBRT building is the bioprocessing pilot plant, consisting of extensive upstream, downstream, fill-finish and the associated analytical facilities. These facilities are all operated in a realistic GMP simulated, operational manufacturing environment.

Application date

How to apply?
The following entry routes are available:
MEngSc Biopharmaceutical Engineering FT (T070)

Duration
1 Years

Attendance
Full Time

Deadline
Rolling *
Apply Now

MEngSc Biopharmaceutical Engineering PT (T015)
Duration
2 Years

Attendance
Part Time

Deadline
Rolling *

* Courses will remain open until such time as all places have been filled, therefore early application is advised.

Course fee

MEngSc Biopharmaceutical Engineering (T015) Part Time
EU Year 1 - €6000
EU Year 2 - €4120 aa
nonEU Year 1 - €12400
nonEU Year 2 - €12100 aa
nonEU Year 3 - €5950 vb

MEngSc Biopharmaceutical Engineering (T070) Full Time
EU fee per year - €7830
nonEU fee per year - €24800

aaSecond Year Fee applies to Students in 2nd Year in 2019 and who were a 1st Year Student on the programme in 2018/19

vbThird Year Fee applies to Students in 3rd Year in 2019 and who were a 1st Year Student on the programme in 2017/18
***Fees are subject to change

Please note that UCD offers a number of graduate scholarships for full-time, self-funding international students, holding an offer of a place on a UCD graduate degree programme. For further information please see www.ucd.ie/international/scholarships.

The College of Engineering & Architecture also offer scholarships for non-EU students, for more information see: www.ucd.ie/eacollege/study/noneuscholarships.

Enrolment and start dates

Next Intake: 2019/2020 September

Remember to mention gradireland when contacting institutions!